These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15200288)

  • 1. Quantification of the pathological changes in the temporal lobe of patients with a novel neurofilamentopathy: neurofilament inclusion disease (NID).
    Cairns NJ; Armstrong RA
    Clin Neuropathol; 2004; 23(3):107-12. PubMed ID: 15200288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study original using alpha-internexin immunohistochemistry.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2006; 25(5):209-15. PubMed ID: 17007442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal lobe pathology of human patients with neurofilament inclusion disease.
    Cairns NJ; Jaros E; Perry RH; Armstrong RA
    Neurosci Lett; 2004 Jan; 354(3):245-7. PubMed ID: 14700742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial correlations between the neuronal inclusions, swollen achromatic neurons, and glial cells in neuronal intermediate filament inclusion disease (NIFID).
    Cairns NJ; Armstrong RA
    J Neural Transm (Vienna); 2005 Apr; 112(4):473-80. PubMed ID: 15375676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration.
    Armstrong RA; Cairns NJ; Lantos PL
    Exp Neurol; 2000 Jun; 163(2):348-56. PubMed ID: 10833308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex--a study in ten patients.
    Armstrong RA; Lantos PL; Cairns NJ
    Clin Neuropathol; 2005; 24(5):230-5. PubMed ID: 16167547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
    Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
    J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial patterns of the pathological changes in the temporal lobe of patients with neuronal intermediate filament inclusion disease.
    Cairns NJ; Armstrong RA
    Neuropathology; 2005 Dec; 25(4):298-303. PubMed ID: 16382778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).
    Armstrong RA; Kerty E; Skullerud K; Cairns NJ
    J Neural Transm (Vienna); 2006 Sep; 113(9):1207-15. PubMed ID: 16362634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
    Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
    Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.
    Josephs KA; Holton JL; Rossor MN; Godbolt AK; Ozawa T; Strand K; Khan N; Al-Sarraj S; Revesz T
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):369-73. PubMed ID: 15305982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustering of Pick bodies in the dentate gyrus in Pick's disease.
    Armstrong RA; Cairns NJ; Lantos PL
    Neuropathology; 2000 Sep; 20(3):170-5. PubMed ID: 11132931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the clinicopathological spectrum of neurofilament inclusion disease.
    Josephs KA; Uchikado H; McComb RD; Bashir R; Wszolek Z; Swanson J; Matsumoto J; Shaw G; Dickson DW
    Acta Neuropathol; 2005 Apr; 109(4):427-32. PubMed ID: 15754170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
    Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
    Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Densities of parvalbumin-immunoreactive neurons in non-malformed hippocampal sclerosis-temporal neocortex and in cortical dysplasias.
    Zamecnik J; Krsek P; Druga R; Marusic P; Benes V; Tichy M; Komarek V
    Brain Res Bull; 2006 Feb; 68(6):474-81. PubMed ID: 16459206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C expression is associated with granule cell dispersion in epilepsy.
    Pirttilä TJ; Manninen A; Jutila L; Nissinen J; Kälviäinen R; Vapalahti M; Immonen A; Paljärvi L; Karkola K; Alafuzoff I; Mervaala E; Pitkänen A
    Ann Neurol; 2005 Aug; 58(2):211-23. PubMed ID: 16049933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.
    Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
    Acta Neuropathol; 2011 Feb; 121(2):219-28. PubMed ID: 20886222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.